UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.312

Sortiert nach

Molecular approaches to personalizing management of ovarian cancer

Annals of oncology, 2011-12, Vol.22 Suppl 8 (Suppl 8), p.viii5-viii15

Bast, Jr, R C

2011

Volltextzugriff (PDF)

Screening for ovarian cancer: imaging challenges and opportunities for improvement

Ultrasound in obstetrics & gynecology, 2018-03, Vol.51 (3), p.293-303

2018

Volltextzugriff (PDF)

HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy

Oncogene, 2006-11, Vol.25 (52), p.6986-6996

2006

Volltextzugriff (PDF)

ARHI (DIRAS3) induces autophagy in ovarian cancer cells by downregulating the epidermal growth factor receptor, inhibiting PI3K and Ras/MAP signaling and activating the FOXo3a-mediated induction of Rab7

Cell death and differentiation, 2014-08, Vol.21 (8), p.1275-1289

2014

Volltextzugriff (PDF)

Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway

Oncogene, 2016-05, Vol.35 (19), p.2506-2517

2016

Volltextzugriff (PDF)

Phosphorylation and Inactivation of Glycogen Synthase Kinase 3 by Protein Kinase A

Proceedings of the National Academy of Sciences - PNAS, 2000-10, Vol.97 (22), p.11960-11965

2000

Volltextzugriff (PDF)

2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1865-1878

2001

Volltextzugriff (PDF)

A rapid and efficient ion-exchange chromatography for Lu–Hf, Sm–Nd, and Rb–Sr geochronology and the routine isotope analysis of sub-ng amounts of Hf by MC-ICP-MS

Journal of analytical atomic spectrometry, 2015-01, Vol.30 (11), p.2323-2333

2015

Volltextzugriff (PDF)

Linking genomic reorganization to tumor initiation via the giant cell cycle

Oncogenesis (New York, NY), 2016-12, Vol.5 (12), p.e281-e281

2016

Volltextzugriff (PDF)

The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways

Oncogene, 2012-01, Vol.31 (1), p.68-79

2012

Volltextzugriff (PDF)

ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts

Cell death & disease, 2015-08, Vol.6 (8), p.e1836-e1836

2015

Volltextzugriff (PDF)

New tumor markers: CA125 and beyond

International journal of gynecological cancer, 2005-11, Vol.15 (s3), p.274-281

2005

Volltextzugriff (PDF)

Neurosensory component of hand–arm vibration syndrome: a 22-year follow-up study

Occupational medicine (Oxford), 2019-05, Vol.69 (3), p.215-218

2019

Volltextzugriff (PDF)

Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway

Oncogene, 1999-11, Vol.18 (48), p.6635-6640

1999

Volltextzugriff (PDF)

The origin of ovarian cancer

BJOG : an international journal of obstetrics and gynaecology, 2012-01, Vol.119 (2), p.134-136

2012

Volltextzugriff (PDF)

Cyclin G1 regulates the outcome of taxane-induced mitotic checkpoint arrest

Oncogene, 2012-05, Vol.31 (19), p.2450-2460

2012

Volltextzugriff (PDF)

Status of Tumor Markers in Ovarian Cancer Screening

Journal of clinical oncology, 2003-05, Vol.21 (10 suppl), p.200s-205

Bast, Jr, Robert C

2003

Volltextzugriff (PDF)

Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers

JNCI : Journal of the National Cancer Institute, 1996-10, Vol.88 (20), p.1456-1466

1996

Volltextzugriff (PDF)

Communication skills training in oncology : Description and preliminary outcomes of workshops on breaking bad news and managing patient reactions to illness

Cancer, 1999-09, Vol.86 (5), p.887-897

1999

Volltextzugriff (PDF)

Genetic analysis of early- versus late-stage ovarian tumors

Cancer research (Chicago, Ill.), 2001-08, Vol.61 (15), p.5895-5904

2001

Volltextzugriff (PDF)

NOEY2 (ARHI), an Imprinted Putative Tumor Suppressor Gene in Ovarian and Breast Carcinomas

Proceedings of the National Academy of Sciences - PNAS, 1999-01, Vol.96 (1), p.214-219

1999

Volltextzugriff (PDF)

Metasomatism of gabbro - mineral replacement and element mobilization during the Sveconorwegian metamorphic event

Journal of metamorphic geology, 2011-05, Vol.29 (4), p.399-423

2011

Volltextzugriff (PDF)

High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer

Journal of clinical oncology, 1993-06, Vol.11 (6), p.1132-1143

1993

Volltextzugriff (PDF)

Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor

Nature (London), 1994-08, Vol.370 (6490), p.558-561

1994

Volltextzugriff (PDF)

Boron isotopes in tourmaline as a tracer of metasomatic processes in the Bamble sector of Southern Norway

Contributions to mineralogy and petrology, 2014-10, Vol.168 (4), p.1, Article 1069

2014

Volltextzugriff (PDF)

1 – 25 von 1.312

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.181)
Mit Volltextzugriff
(1.132)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(815)
Life Sciences & Biomedicine
(757)
Humans
(666)
Female
(460)
Biological And Medical Sciences
(458)
Medical Sciences
(377)
Male
(279)
Animals
(272)
Oncology
(245)
Middle Aged
(176)
Adult
(165)
Tumors
(162)
Gynecology. Andrology. Obstetrics
(132)
Pharmacology. Drug Treatments
(122)
Female Genital Diseases
(117)
Aged
(110)
Pharmacology & Pharmacy
(108)
Biochemistry & Molecular Biology
(98)
Fundamental And Applied Biological Sciences. Psychology
(91)
Mice
(88)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Molecular approaches to personalizing management of ovarian cancer

Screening for ovarian cancer: imaging challenges and opportunities for improvement

HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy

ARHI (DIRAS3) induces autophagy in ovarian cancer cells by downregulating the epidermal growth factor receptor, inhibiting PI3K and Ras/MAP signaling and activating the FOXo3a-mediated induction of Rab7

Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway

Phosphorylation and Inactivation of Glycogen Synthase Kinase 3 by Protein Kinase A

2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology

A rapid and efficient ion-exchange chromatography for Lu–Hf, Sm–Nd, and Rb–Sr geochronology and the routine isotope analysis of sub-ng amounts of Hf by MC-ICP-MS

Linking genomic reorganization to tumor initiation via the giant cell cycle

The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways

ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts

New tumor markers: CA125 and beyond

Neurosensory component of hand–arm vibration syndrome: a 22-year follow-up study

Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway

The origin of ovarian cancer

Cyclin G1 regulates the outcome of taxane-induced mitotic checkpoint arrest

Status of Tumor Markers in Ovarian Cancer Screening

Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers

Communication skills training in oncology : Description and preliminary outcomes of workshops on breaking bad news and managing patient reactions to illness

Genetic analysis of early- versus late-stage ovarian tumors

NOEY2 (ARHI), an Imprinted Putative Tumor Suppressor Gene in Ovarian and Breast Carcinomas

Metasomatism of gabbro - mineral replacement and element mobilization during the Sveconorwegian metamorphic event

High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer

Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor

Boron isotopes in tourmaline as a tracer of metasomatic processes in the Bamble sector of Southern Norway

Suchergebnisse filtern